Julia Kroth, Dumitru Ciolac, Vinzenz Fleischer, Nabin Koirala, Julia Krämer, Muthuraman Muthuraman, Felix Luessi, Stefan Bittner, Gabriel Gonzalez-Escamilla, Frauke Zipp, Sven G. Meuth, Sergiu Groppa
- Background
Currently, no unequivocal predictors of disease evolution exist in patients with multiple sclerosis (MS). Cortical atrophy measurements are, however, closely associated with cumulative disability.
Objective
Here, we aim to forecast longitudinal magnetic resonance imaging (MRI)-driven cortical atrophy and clinical disability from cerebrospinal fluid (CSF) markers.
Methods
We analyzed CSF fractions of albumin and immunoglobulins (Ig) A, G, and M and their CSF to serum quotients.
Results
Widespread atrophy was highly associated with increased baseline CSF concentrations and quotients of albumin and IgA. Patients with increased CSFIgA and CSFIgM showed higher functional disability at follow-up.
Conclusion
CSF markers of blood–brain barrier integrity and specific immune response forecast emerging gray matter pathology and disease progression in MS.